Ghrelin analogs
A compound, -A1-A2-A3-A4-A5-A6-A7-A8-A9-A10-A11-A12-A13-A14-A15-A16-A17-A18-A19-A20-A20-A21-A22 - The technology of A23-A24-A25-A26-A27-A28-R1 is applied in the direction of hormone peptides, animal/human proteins, peptide/protein components, etc., and can solve the problem of low oral bioavailability and stimulation of peptidyl growth hormone secretagogue Non-peptide compound research and other issues
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0882] Embodiment 1: (Glu 3 (O-hexyl))hGhrelin(1-28)-NH 2
[0883] The title peptide was synthesized on an Applied Biosystems (Foster City, CA) Model 433A Peptide Synthesizer. 4-(2',4'-dimethoxyphenyl-Fmoc-aminomethyl)-phenoxyacetamide-norleucyl-MBHA resin (Rink Amide MBHA resin) with 0.72mmol / g substituent was used , Novabiochem, San Diego, CA). Fmoc amino acids (AnaSpec, San Jose, CA) with the following side chain protections were used: Fmoc-Arg(Pbf)-OH, Fmoc-Pro-OH, Fmoc-Gln-OH, Fmoc-Leu-OH, Fmoc-Lys(Boc )-OH, Fmoc-Ala-OH, Fmoc-Ser(tBu)-OH, Fmoc-Glu(OtBu)-OH, Fmoc-Val-OH, Fmoc-His(Trt)-OH, Fmoc-Phe-OH, and Fmoc-Asp(OtBu)-OH. Boc-Gly-OH (Midwest Bio-Tech, Fishers, IN) was used in position 1. N-α-Fmoc-L-glutamic acid γ-4-{N-(1-(4,4-Dimethyl-2,6-dioxocyclohexylene)-3-methylbutyl)-amino } Benzyl ester (Fmoc-Glu(ODmab)-OH) (Chem-Inpex International, WoodDale, IL) was used at position 3. Synthesis was performed on a 0.25 mmol scale. The Fmoc group was removed by treatment...
Embodiment 2
[0885] Embodiment 2: (Aib 2 )hGhrelin(1-28)-NH 2
[0886] According to the synthesis described in Example 1 (Glu 3 (O-hexyl))hGhrelin(1-28)-NH 2 The title peptides were synthesized by the method described above, except for the following: Fmoc-Ser-OH for position 3, Fmoc-Aib-OH for position 2, and Boc-Gly-OH for position 1. After assembly of the peptide chains, the peptide-resin was treated with 25% piperidine in DMF for 3 x 2 h. The resin was washed with DMF and treated with octanoic acid (2.5 mmol, 10-fold excess), HBTU (2.2 mmol), HOBt (2.2 mmol) and DIEA (7.5 mmol) in DMF for 2 h. The resin was washed with DMF and treated with octanoic acid (2.5 mmol), DIC (2.5 mmol), HOBt (2.5 mmol) and DMAP (0.025 mmol) in DMF for 2 h. The final cleavage and purification steps are the same as in Example 1. Analytical HPLC determined that the product was homogeneous with a purity of 99% and a yield of 18.5%.
[0887] The molecular weight of the surface product analyzed by electrospr...
Embodiment 3
[0888] Embodiment 3: (Glu 3 (NH-hexyl))hGhrelin(1-28)-NH 2
[0889] The title peptide was synthesized on an Applied Biosystems (Foster City, CA) Model 430A Peptide Synthesizer modified for accelerated Boc-chemical solid-phase peptide synthesis, see Schnolzer, et al., Int. J. Ppetide Protein Res., 40:180 (1992 ). 4-Methylbenzhydrylamine (MBHA) resin (Peninsula, Belmont, CA) with 0.91 mmol / g substituent was used. Boc amino acids (Midwest Bio-Tech, Fishers, IN; Novabiochem, San Diego, CA) with the following side chain protections were used: Boc-Ala-OH, Boc-Arg(Tos)-OH, Boc-His(DNP)-OH , Boc-Val-OH, Boc-Leu-OH, Boc-Gly-OH, Boc-Gln-OH, Boc-Lys(2ClZ)-OH, Boc-Ser(Bzl)-OH, Boc-Phe-OH, Boc -Glu(OcHex)-OH and Boc-Pro-OH. Position 3 in the residue sequence used Fmoc-Glu(OtBu)-OH (Novabiochem, San Diego, CA). Synthesis was performed on a scale of 0.25 mmol. Treat with 100% TFA for 2×1 min to remove the Boc group. Boc amino acids (2.5 mmol) were preactivated with HBTU (2.0 mmol) an...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com